22 research outputs found

    Determination of Leptoquark Properties in Polarized eγe\gamma Collisions

    Full text link
    We study leptoquark production using polarized eγe\gamma colliders for the center of mass energies s=500\sqrt s=500~GeV and 1~TeV. We show that using polarization asymmetries the ten different types of leptoquarks listed by Buchm\"uller, R\"uckl and Wyler can be distinquished from one another for leptoquark masses essentially up to the kinematic limit of the respective colliders. Thus, if a leptoquark were discovered an eγe\gamma collider could play a crucial role in determining its origins.Comment: 10 pages (plus 10 postscript figures submitted separately), OCIP/C 94-

    Resolved Photon Contributions to Leptoquark Production in e+ee^+ e^- and eγe\gamma Collision

    Full text link
    We calculate the resolved photon contribution to leptoquark production at eγe\gamma colliders for the center of mass energies s=500\sqrt s=500~GeV and 1~TeV. We also calculate the resolved photon contribution to leptoquark production at e+ee^+ e^- colliders for the center of mass energies s=1\sqrt{s} = 1~and~2~TeV. In both cases we find that these contributions are considerably larger than the standard contributions considered in the literature.Comment: 9 pages (5 postscript figures in separate uuencoded file), OCIP/C 93-1

    Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

    Get PDF
    BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

    Electroanalytical and surface studies on the protective action of a coating of PVA@3WGO on mild steel in acidic and saline environment

    No full text
    Corrosion aversion capability of Polyvinyl alcohol (PVA) coatings with different loading levels of Graphene Oxide (GO) nanoparticles on mild steel testing panels has been studied in different aggressive media. The chemical structure of the developed coatings was studied by FTIR, UV–Visible,​ and X-ray diffraction studies. The viability of the coating to offer corrosion resistance and the barrier performance were investigated by potentiodynamic polarization and electrochemical impedance spectroscopy. The surface morphology of the material was characterized by FESEM and AFM techniques. The electrochemical and non-electrochemical corrosion study of the coated panels were compared with uncoated mild steel panel and showed that PVA polymer matrix filled with 3.0 weight % of GO (PVA@3WGO) gives better protection in 0.5M HCl and 3.5% NaCl
    corecore